التفاصيل البيبلوغرافية
| العنوان: |
The shifting landscape of conjunctival hyperemia. |
| المؤلفون: |
Hayes, Hattie, Salgado-Borges, José |
| المصدر: |
Ophthalmology Times Europe; Jul/Aug2024, Vol. 20 Issue 6, p6-8, 3p |
| مصطلحات موضوعية: |
ADRENERGIC receptors, EYE drops, GENERAL practitioners, ALLERGIC rhinitis, DRY eye syndromes, ALLERGIC conjunctivitis |
| مستخلص: |
The article discusses the shifting landscape of conjunctival hyperemia, a condition characterized by redness, watering, and irritation in the eyes. Patients with conjunctival hyperemia are increasingly aware of the treatment options available to them and the ones that remain inaccessible. Changes in the European market have added new challenges for patients and practitioners, with several ocular products being recalled or facing safety concerns. Brimonidine tartrate 0.025% has recently received regulatory approval in Europe, providing a new treatment option for patients. However, clinicians should carefully consider the limitations and monitor other ocular and non-ocular symptoms when prescribing this medication. Accessing and affording medications will be a concern for patients in Europe, and education is crucial for clinicians to help patients make informed decisions. [Extracted from the article] |
|
Copyright of Ophthalmology Times Europe is the property of MJH Life Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
